AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

VIGL(Delisted)

Vigil Neuroscience·NASDAQ
--
--(--)

Vigil Neuroscience (VIGL) Financial Ratios and Key Metrics

View Vigil Neuroscience (VIGL) financial ratios, including profitability, valuation, solvency, liquidity, operating efficiency, and per-share metrics. Compare annual, quarterly, and TTM data to better understand the company's financial performance.

Currency:USD
Q3'20Sep 2020Q4'20Dec 2020Q1'21Mar 2021Q2'21Jun 2021Q3'21Sep 2021Q4'21Dec 2021Q1'22Mar 2022Q2'22Jun 2022Q3'22Sep 2022Q4'22Dec 2022Q1'23Mar 2023Q2'23Jun 2023Q3'23Sep 2023Q4'23Dec 2023Q1'24Mar 2024Q2'24Jun 2024Q3'24Sep 2024Q4'24Dec 2024Q1'25Mar 2025Q2'25Jun 2025
Return on Capital
----------------------------------------
----------------------------------------
----------------------------------------
Profitability
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
Cost Structure
----------------------------------------
----------------------------------------
Solvency
--0.26----0.080.100.040.050.040.060.110.120.150.170.170.210.330.390.390.52
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
Liquidity
----------------------------------------
--12.68----11.669.8725.8321.3522.1917.4923.3019.0713.7910.4512.388.393.722.952.972.06
--12.68----11.669.8725.8321.3522.1917.4923.3019.0713.7910.4512.388.393.722.952.972.06
----------------------------------------
Operating Efficiency
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
Per Share Metrics
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------
----------------------------------------